Tower Research Capital LLC (TRC) - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 32 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q2 2016$1,000
-85.7%
474
-84.6%
0.00%
-100.0%
Q1 2016$7,000
+133.3%
3,076
+810.1%
0.00%
Q2 2015$3,000
+50.0%
338
+21.1%
0.00%
Q1 2015$2,000
-33.3%
279
-49.9%
0.00%
Q4 2014$3,000
+200.0%
557
+312.6%
0.00%
Q3 2014$1,0000.0%135
+32.4%
0.00%
Q2 2014$1,000
-50.0%
102
-49.5%
0.00%
Q1 2014$2,000
-85.7%
202
-84.7%
0.00%
-100.0%
Q4 2013$14,000
+366.7%
1,316
+44.5%
0.00%
Q3 2013$3,0009110.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2015
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders